Delivery Order SPE2DB22D1017-SPE2DB24FG2UA
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price of $1,013.45 and a completion date of February 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,773.57, is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 5, 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.96 firm-fixed-price contract is for the supply of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a medication used for diabetes management. The contract has a period of performance through March 5, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Lyumjev 100 Unit/mL Vial 10mL, a pharmaceutical product. The award, valued at $1,296.36, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,315.66 firm fixed price delivery order to provide LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LYUMJEV 200 UNIT/ML KWIKPEN 3ML, a diabetes treatment medication, with a ceiling value of $3,926.76 and a performance period through May 20, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,334.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of LYUMJEV 100 UNIT/ML KWIKPEN 3ML, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred fifty dollars and nine cents to Amerisourcebergen Drug Corporation for LYUMJEV 100 unit/ml vials. As the prime contractor, Amerisourcebergen Drug Corporation will deliver ten milliliters of the diabetes medication in vials to a location in Conshohocken, Pennsylvania by July 24, 2023 to fulfill requirements under the Agency's pharmaceutical supply chain program. The order was funded by the Defense...
The Defense Logistics Agency awarded a $800 delivery order to Amerisourcebergen Drug Corporation for LYUMJEV 100 unit/ml vials. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the diabetes medication to a facility in Conshohocken, Pennsylvania within a firm fixed price contract starting August 11th and concluding on the 14th of 2023. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies for the U.S. Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 Unit/mL insulin vials, with a ceiling value of $2,732.40 and a completion date of January 20, 2023. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...